US 9051324
Modulators of cystic fibrosis transmembrane conductance regulator
granted A61KA61K31/519A61K45/06
Quick answer
US patent 9051324 (Modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/519, A61K45/06, A61P, A61P1/10